Monoclonal antibodies against 12 of the 17 IATS serotype strains ofPseudomonas aeruginosa were produced. Eighty-seven hybridoma clones were isolated, and the antibodies secreted were found to be reactive with both Formalin-fixed whole cells and purified lipopolysaccharide of homologous strains in enzyme-linked immunosorbent assays. Among these monoclonal antibodies, the predominant antibody class was 
the 0 antigen of corresponding serotypes of clinical isolates from cystic fibrosis patients. In conclusion, a set of monoclonal antibodies against the IATS serotype strains of P. aeruginosa have been produced. These antibodies represent a bank of invaluable immunological reagents which may have application in serotyping, epitope mapping, Iipopolysaccharide structural determination, and studies of protection against P. aeruginosa.
The differences among the 0 antigen side chains of lipopolysaccharide (LPS) of Pseudomonas aeruginosa form the basis of the serotyping system for this organism. Due to the existence of a relatively large number of such systems established by various investigators around the world, a standardized serotyping system known as the International Antigenic Typing Scheme (IATS) consisting of 17 standard 0-antigenic serotypes has been proposed (3, 28) . To complement this proposed scheme, commercial antisera against each of the 17 0 types were produced by Difco Laboratories (Detroit, Mich.). In most epidemiological studies, more than 90% of clinical isolates can usually be allocated to a specific O type (3, 42) by means of the standard slide or tube agglutination method. However, difficulties can still be encountered when a small number of strains agglutinate with more than one antiserum even when the sera have been absorbed (28) . This and other major typing problems are illustrated by P. aeruginosa isolates from cystic fibrosis patients. These strains are often difficult to serotype and are classified as nontypable since they either do not type with any typing sera, autoagglutinate, or polyagglutinate with more than one 0 antigen-specific typing serum (16, 32, 35, 40, 43) . These abnormal typing patterns, occurring in up to 60% of cystic fibrosis isolates, were found by Hancock et al. (16) to correlate with deficiencies in the amount of 0 antigen in the LPS of these strains. The above-mentioned limitations of the existing serotyping system for P. aeruginosa warrant the development of monoclonal antibodies (MAbs) with improved specificity of interaction with each serotype.
MAbs, with their obvious advantages over polyclonal sera, including availability, specificity, and reproducibility, are gradually replacing rabbit antibodies as the immunological reagent of choice for serotyping and the analysis of bacterial cell surface antigens (25, 35) . Joly et al. (19) (21) , and Vibrio cholerae group 0:1 (14) . These MAbs were used either for mapping common epitopes from one strain to the next, for subtyping strains in the same serogroup, or for correlating the immunological relatedness of LPS to structural studies. Due to the importance of LPS as a virulence factor (9, 10) and a major protective antigen in the pseudomonal extract vaccine (29, 30) (36) but with slight modifications. The fusogen used consisted of 40% polyethylene glycol (Mr, 1,300 to 1,600; Sigma Chemical Co., St. Louis, Mo.) with 4% dimethyl sulfoxide (Sigma) (27) (45) , outer membrane preparations were also used to immunoblot with LPS-specific MAbs. After reacting with MAbs, the nitrocellulose blots were developed at room temperature by using a goat anti-mouse F(ab')2 alkaline phosphatase-conjugated antibody (Helix Biotech, Vancouver, British Columbia) and a substrate consisting of 20 mg of TR fast red (Sigma) and 10 mng of napthol AS-MX phosphate (Sigma) in 10 ml of 50 mM Tris hydrochloride, pH 8.8. Double immunodiffusion. The double-diffusion in gel method was performed in 1% (wt/vol) agarose in Trisbarbital buffer as described previously (26) . The antigen wells were filled with sonicated whole-cell antigens, and the antibody wells were filled with undiluted or twofold dilutions of hybridoma culture supernatants and ascitic fluid.
RESULTS
Isolation of LPS-specific hybridomas. From every fusion experiment performed, hybridomas were identified consistently in more than 70% of all the tissue culture wells. The hybridomas secreted antibodies that reacted with Formalinfixed whole-cell antigens of homologous P. aeruginosa strains when assayed by ELISA. However, only those hybrids secreting MAbs that also reacted with purified LPS of the same strain were selected and expanded for cloning and antibody production by the ascites method. A total of 87 clones (of more than 4,000 hybrids) were isolated and characterized. The culture supernatants of these hybridomas were highly reactive with 0.5 ,ug of LPS when assayed by (Fig. 1D ). This ladderlike banding pattern was characteristic of the migration of 0 antigens in SDS-PAGE (Fig.  1C) . Interaction between the rough core region of the electrophoretically separated LPS and the agglutinating MAbs was not observed in most cases. Only the 09-specific MAb MF43-4 was found to blot the core as well as the 0 antigen portion of homologous LPS. In contrast, the nonagglutinating MAbs did not blot with any of the 0 side chain bands when LPS was used as the blotting antigen (Fig. 1E) . It was intriguing to find, however, that the same antibodies blotted with major outer membrane protein bands (Fig. 1B  and E sera in agglutination reactions. In particular, significant cross-reactions were seen between the following groups: 02 and 05, 07 and 08, and 013 and 014 (28) . Such observations were reconfirmed by us. When the same bacterial strains were tested for cross-reactions with MAbs, only one cross-reacting group, involving 07 and 08 strains of P. aeruginosa, was observed. MAbs raised against IATS 07 or IATS 08 strains agglutinated both strains. This dramatic decrease in cross-reactions among the 0 groups clearly demonstrated the superior specificity of MAbs over the polyclonal rabbit sera currently used for serotyping.
Interaction of MAbs with clinical isolates from cystic fibrosis patients. To determine whether our MAbs can be used to type P. aeruginosa strains other than the well-defined IATS strains, four groups of clinical isolates of serotype 01, 05, 06, and 09 were tested for their interactions with MAbs in slide agglutination and immunoblotting experiments (Table  2) . When the serotype 01-specific MAb MF25-3 was tested against the group of 01 strains, it agglutinated all seven strains of the group and also blotted with the ladderlike bands of the 0 antigen of all these strains. Similar results were obtained when the 05-specific MAb MF15-1 was tested against eight 05 strains. The serotype 06-specific MAb MF23-2 agglutinated all but two (strains CF651M and CF511C) of the nine 06 strains tested. In immunoblotting (Fig. 1D) . Presumably, such ladderlike bands of the 0 antigen side chains of P. aeruginosa resemble the Salmonella LPS bands (38) in that each adjacent band differs by one repeating tri-to tetrasaccharide attached to the core oligosaccharides. The antigen specificity of the group of nonagglutinating MAbs appeared to be directed towards epitopes other than the 0 antigen of the LPS because they reacted with purified LPS in the ELISA but did not immunoblot with the ladderlike banding pattern of the 0 antigen side chains or the lower-molecular-weight rough core bands. In addition, when outer membrane was used as the blotting antigen, each of these MAbs interacted with all of the major outer membrane protein bands, including protein D, protein E, protein F, protein H2, and protein I. These antibodies cannot be outer membrane protein specific, however, because being monospecific, they would not have interacted with all of the major outer membrane protein bands. In addition, the antigenic uniqueness of outer membrane proteins has been observed in earlier studies, in which MAbs MA4-4 and MA1-6 reacted specifically with protein F and protein H2 of P. aeruginosa, respectively (25, 26, 34) . The only conclusion we could draw from these observations was that the nonagglutinating antibodies interacted with a common LPS structure associated with all outer membrane proteins. This assumption is supportive of the findings by Poxton et al. (45) Cross-reactions of P. aeruginosa heat-stable antigens (predominantly 0 antigen of the LPS) with more than one of the Difco pseudomonal typing sera are not uncommon (28) . Even after absorption, Kusama (24) still found some P. aeruginosa strains to agglutinate with more than one serotype-specific serum. Significantly strong cross-reactions between serogroups 07 and 08 were observed in previous studies (28) . In fact, there were suggestions to combine these two serogroups into one so that the IATS would consist of 16 instead of 17 serogroups. In our study with MAbs, only one cross-reacting group among the 17 serotype strains, involving serogroups 07 and 08, was identified. Thus, 07 and 08 strains probably have a common epitope on their 0 antigens. However, an earlier report by Knirel et al. (23) has demonstrated that differences between Lanyi serotypes 0:3a,d and 0:3a,b differed only by ana instead of a 13 linkage between two sugars. Such evidence suggests that one should be able to obtain unique as well as cross-reactive MAbs against most serotypes of P. aeruginosa. Further work is warranted to isolate serotype-specific MAbs against each of the 07 and 08 serogroups. The fact that we could not detect more cross-reacting groups with the MAbs demonstrates the superior monospecific reactivity of these immune probes in serotyping compared with results published previously with polyclonal rabbit sera (28) .
In conclusion, we have produced a significantly extensive bank of MAbs against the IATS serotype strains of P. aeruginosa. These antibodies have been characterized to determine their serotyping potential by the standard slide agglutination and the more sensitive Western immunoblotting technique. Slide agglutination was chosen because of its speed and simplicity and the relatively minute amount of antibodies required per test. The feasibility of using other techniques such as immunofluorescence, passive hemagglutination and dot immunoblotting for serotyping with MAbs is currently being investigated. 
